Works matching AU Michiue, Hiroyuki


Results: 33
    1
    2
    3
    4
    5

    ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer.

    Published in:
    Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02312-y
    By:
    • Umeda, Hibiki;
    • Shigeyasu, Kunitoshi;
    • Takahashi, Toshiaki;
    • Moriwake, Kazuya;
    • Kondo, Yoshitaka;
    • Yoshida, Kazuhiro;
    • Takeda, Sho;
    • Yano, Shuya;
    • Matsumi, Yuki;
    • Kishimoto, Hiroyuki;
    • Fuji, Tomokazu;
    • Yasui, Kazuya;
    • Yamamoto, Hideki;
    • Takagi, Kosei;
    • Kayano, Masashi;
    • Michiue, Hiroyuki;
    • Nakamura, Keiichiro;
    • Mori, Yoshiko;
    • Teraishi, Fuminori;
    • Tazawa, Hiroshi
    Publication type:
    Article
    6
    7

    ANNEXIN A2 REGULATES ANGIOGENESIS AND INVASION PHENOTYPES OF MALIGNANT GLIOMA.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii10, doi. 10.1093/neuonc/nou206.35
    By:
    • Ichikawa, Tomotsugu;
    • Onishi, Manabu;
    • Kurozumi, Kazuhiko;
    • Maruo, Tomoko;
    • Inoue, Satoshi;
    • Michiue, Hiroyuki;
    • Yoshida, Koichi;
    • Fuji, Kentaro;
    • Ishida, Joji;
    • Shimazu, Yosuke;
    • Oka, Tetsuo;
    • Chiocca, E.A.;
    • Date, Isao
    Publication type:
    Article
    8

    Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.

    Published in:
    International Journal of Cancer, 2024, v. 154, n. 1, p. 169, doi. 10.1002/ijc.34700
    By:
    • Kemmotsu, Naoya;
    • Ninomiya, Kiichiro;
    • Kunimasa, Kei;
    • Ishino, Takamasa;
    • Nagasaki, Joji;
    • Otani, Yoshihiro;
    • Michiue, Hiroyuki;
    • Ichihara, Eiki;
    • Ohashi, Kadoaki;
    • Inoue, Takako;
    • Tamiya, Motohiro;
    • Sakai, Kazuko;
    • Ueda, Youki;
    • Dansako, Hiromichi;
    • Nishio, Kazuto;
    • Kiura, Katsuyuki;
    • Date, Isao;
    • Togashi, Yosuke
    Publication type:
    Article
    9
    10
    11
    12

    Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B‐NIT).

    Published in:
    Cancer Science, 2024, v. 115, n. 10, p. 3231, doi. 10.1111/cas.16298
    By:
    • Fujimoto, Takuya;
    • Yamasaki, Osamu;
    • Kanehira, Noriyuki;
    • Matsushita, Hirokazu;
    • Sakurai, Yoshinori;
    • Kenmotsu, Naoya;
    • Mizuta, Ryo;
    • Kondo, Natsuko;
    • Takata, Takushi;
    • Kitamatsu, Mizuki;
    • Igawa, Kazuyo;
    • Fujimura, Atsushi;
    • Otani, Yoshihiro;
    • Shirakawa, Makoto;
    • Shigeyasu, Kunitoshi;
    • Teraishi, Fuminori;
    • Togashi, Yosuke;
    • Suzuki, Minoru;
    • Fujiwara, Toshiyoshi;
    • Michiue, Hiroyuki
    Publication type:
    Article
    13

    RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.

    Published in:
    Journal of Crohn's & Colitis, 2023, v. 17, n. 5, p. 754, doi. 10.1093/ecco-jcc/jjac186
    By:
    • Takahashi, Kazutaka;
    • Shigeyasu, Kunitoshi;
    • Kondo, Yoshitaka;
    • Gotoh, Kazuyoshi;
    • Yano, Shuya;
    • Umeda, Yuzo;
    • Inokuchi, Toshihiro;
    • Xu, Caiming;
    • Yoshida, Kazuhiro;
    • Umeda, Hibiki;
    • Takahashi, Toshiaki;
    • Takeda, Sho;
    • Yoshida, Ryuichi;
    • Teraishi, Fuminori;
    • Kishimoto, Hiroyuki;
    • Mori, Yoshiko;
    • Noma, Kazuhiro;
    • Okugawa, Yoshinaga;
    • Hiraoka, Sakiko;
    • Michiue, Hiroyuki
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29397-z
    By:
    • Hata, Nanako;
    • Shigeyasu, Kunitoshi;
    • Umeda, Yuzo;
    • Yano, Shuya;
    • Takeda, Sho;
    • Yoshida, Kazuhiro;
    • Fuji, Tomokazu;
    • Yoshida, Ryuichi;
    • Yasui, Kazuya;
    • Umeda, Hibiki;
    • Takahashi, Toshiaki;
    • Kondo, Yoshitaka;
    • Kishimoto, Hiroyuki;
    • Mori, Yoshiko;
    • Teraishi, Fuminori;
    • Yamamoto, Hideki;
    • Michiue, Hiroyuki;
    • Nakamura, Keiichiro;
    • Tazawa, Hiroshi;
    • Fujiwara, Toshiyoshi
    Publication type:
    Article
    28

    RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17773-0
    By:
    • Komatsu, Yasuhiro;
    • Shigeyasu, Kunitoshi;
    • Yano, Shuya;
    • Takeda, Sho;
    • Takahashi, Kazutaka;
    • Hata, Nanako;
    • Umeda, Hibiki;
    • Yoshida, Kazuhiro;
    • Mori, Yoshiko;
    • Yasui, Kazuya;
    • Yoshida, Ryuichi;
    • Kondo, Yoshitaka;
    • Kishimoto, Hiroyuki;
    • Teraishi, Fuminori;
    • Umeda, Yuzo;
    • Kagawa, Shunsuke;
    • Michiue, Hiroyuki;
    • Tazawa, Hiroshi;
    • Goel, Ajay;
    • Fujiwara, Toshiyoshi
    Publication type:
    Article
    29
    30
    31
    32

    Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-024-13370-8
    By:
    • Takahashi, Toshiaki;
    • Shigeyasu, Kunitoshi;
    • Kondo, Yoshitaka;
    • Takeda, Sho;
    • Umeda, Hibiki;
    • Moriwake, Kazuya;
    • Kayano, Masashi;
    • Sakurai, Yuya;
    • Nakamura, Shunsuke;
    • Takahashi, Masafumi;
    • Nitta, Kaori;
    • Yoshida, Kazuhiro;
    • Matsumi, Yuki;
    • Michiue, Hiroyuki;
    • Yamamoto, Hideki;
    • Kishimoto, Hiroyuki;
    • Teraishi, Fuminori;
    • Shoji, Ryohei;
    • Kanaya, Nobuhiko;
    • Kashima, Hajime
    Publication type:
    Article
    33